Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients

Josephine Kolstad, Christopher Zoppo, Jean M. Johnston, Precilla D'Souza, Anna Luisa Kühn, Zeynep Vardar, Ahmet Peker, Asma Hader, Hakki Celik, Connor J. Lewis, Clifford Lindsay, Zubir S. Rentiya, Catherine Lebel, Srinivasan Vedantham, Behroze Vachha, Heather L. Gray-Edwards, Maria T. Acosta, Cynthia J. Tifft, Mohammed Salman Shazeeb

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: GM1 gangliosidosis is a rare lysosomal storage disorder characterized by the accumulation of GM1 gangliosides in neuronal cells, resulting in severe neurodegeneration. Currently, limited data exists on the brain volumetric changes associated with this disease. This study focuses on the late-infantile and juvenile subtypes of type II GM1 gangliosidosis, aiming to quantify brain volumetric characteristics to track disease progression. Methods: Brain volumetric analysis was conducted on 56 MRI scans from 24 type II GM1 patients (8 late-infantile and 16 juvenile) and 19 healthy controls over multiple time points. The analysis included the use of semi-automated segmentation of the whole brain, ventricles, cerebellum, corpus callosum, thalamus, caudate, and lentiform nucleus. A generalized linear model was used to compare the volumetric measurements between the patient groups and healthy controls, accounting for age as a confounding factor. Results: Both late-infantile and juvenile GM1 patients exhibited significant whole-brain atrophy compared to healthy controls, even after adjusting for age. Notably, the late-infantile subtype displayed more pronounced atrophy in the cerebellum, thalamus, and corpus callosum compared to the juvenile subtype. Both late-infantile and juvenile subtypes showed significantly higher ventricular volumes and a significant reduction in all other structure volumes compared to the healthy controls. The volumetric measurements also correlated well with disease severity based on clinical metrics. Conclusions: The findings underscore the distinct brain volumetrics of the late-infantile and juvenile subtypes of GM1 gangliosidosis compared to healthy controls. These quantifications can be used as reliable imaging biomarkers to track disease progression and evaluate responses to therapeutic interventions.

Original languageEnglish (US)
Article number109025
JournalMolecular Genetics and Metabolism
Volume144
Issue number3
DOIs
StatePublished - Mar 2025
Externally publishedYes

Keywords

  • Brain
  • GM1 gangliosidosis
  • MRI
  • Volumetrics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Fingerprint

Dive into the research topics of 'Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients'. Together they form a unique fingerprint.

Cite this